Abstract mended by the manufacturer, especialiy in tropical Objective-To determine whether present harbours and during inland transport. Except for methods of international transport of essential drugs ergometrine and methylergometrine the transport by sea adversely affect their quality.
benzylpeniciliin, phenoxymethylpenicillin, and in tropical climates. The other criteria were that Unicef Dr Hogerzeil. tetracycline were not affected by transport. has a high turnover of the drug in volume or in value Conclusions-Drugs were exposed to a much and in medical relevance. Eleven drugs were selected. BMJ 1992; 304:210-4 higer temperature and humidity than is recoin-All samples were taken from normal Unicef stock, and products in the test and control packs were taken from the same batch. Three sea routes were chosen that together cover 35 of the 77 countries served by Unicef and nearly 40% of the total volume of drugs dispatched in 1987. The journeys from Copenhagen to Lagos (Nigeria), to Mombasa and overland to Kampala (Uganda), and to Bangkok (Thailand) took 51, 52, and 27 days respectively 10-30% of the time was spent in the port of destination before customs clearance.
Battery operated "autolog" devices were developed that electronically measured and recorded temperature and relative humidity at three hourly intervals over 100 days. The test packs were the normal Unicef triple wall cardboard boxes containing the selected drugs and the autolog. Four test packs were included in each of the shipments and were put in different locations on board (one pack in the centre and one near the ceiling of two containers, one located in the hold and the other on deck). After arrival and clearance from customs the test packs were sent by air to the chemical laboratories of the Medical Products Agency in Uppsala, Sweden, where control packs had been kept and where the chemical analyses were done. Unfortunately, the test packs from Bangkok were returned by surface mail. The climatic recordings of that journey were used but the drugs were excuded from the analysis.
Results
The temperatures recorded within the test packs ranged from -3 5°C to 33-6°C during the journey to Lagos, from -2 3°C to 42 4°C during the journey to Kampala, and from 1-9°C to 37 5°C during the journey to Bangkok. Relative humidity ranged from 20% to 88%. The temperature within the test packs was usually 3-12°C higher than the ambient temperature. Differences between the locations on board were negligible. The figure shows a sample recording from the trip to Mombasa and overland to Kampala.
Three of the 11 drugs (ergometrine injection, methylergometrine injection, and retinol capsules) lost 1-5-5-8% of their active ingredient during the journey ( Only one study has been published on the climatic pattern during transport of drugs in tropical climates; this study described the temperature within a box of emergency drugs kept in a life raft on board a naval vessel during a voyage in the Indian Ocean.'0 The highest temperature recorded in that box was 40 2°C, in Mombasa. Humidity and quality of the drugs were not studied.
The WHO defines normal drug storage conditions as dry, well ventilated premises at temperatures of 15-25°C or, depending on climatic conditions, up to 30'C.2 In our study the temperature in the drug packs was at times much higher than that, with a maximum of 42 4°C in Mombasa. We also found that the temperature within the packs was 3-12°C higher than the ambient temperature and that periods of great fluctuation occurred in which expansion and contraction could cause drug packages to leak.
The temperature and relative humidity at sea were less of a problem than on land. Extreme climatic conditions occurred especially during time in the harbour and in bond in the port area, and during transport over land. Drugs were exposed to high temperature and humidity for 17 (33%) days on the journey to Lagos and 26 (54%) days on the journey to Kampala.
Three drugs (ergometrine, methylergometrine, and retinol) showed decreased concentrations of active ingredient after international transport. For retinol this had no medical and practical implications: the loss was only 1-5%, the product contained an extra 20% of active ingredient, and the therapeutic margin is wide.
The loss of active ingredient is more important for ergometrine. In a study of 24 field samples from Bangladesh, South Yemen, and Zimbabwe only nine complied with British Pharmacopoeia requirements and seven contained less than 20% of the stated amount of active ingredient.6 Recent data from WHO on samples from Gambia, Malawi, and Zimbabwe confirm this finding. In a longitudinal study in Sudan the drug preparation lost 10% of its active ingredient during the first few months in Port Sudan and was found to contain only 53% of the stated contents after 25 months in the country. 7 The large variation we found between individual ergometrine ampoules is worrying, with three out of 80 BMJ VOLUME 304
25 JANUARY 1992 containing less than 60% of the stated amount. This to depend on protection against humidity, even under observation is much more important than the average exposure to high temperatures. loss of 5 8%. It should also be realised that the product had probably already lost some active ingredient before This study was funded through grants from Unicef and shipment and that further loss would be expected Swedish International Development Authority/Swedish during inland transport and storage. Geneesmniddelen, 1983 . is the best replacement," but its stability in tropical 4 World Health Organisation. Accelerated stability studies of widely used pharmaceutical substances under simulated tropical conditions. Geneva: WHO, 1986. climates is not known either.
